UBS Reiterates Schroders (SHNWF) Buy Recommendation

UBS reiterated a "Buy" recommendation for Schroders (OTCPK:SHNWF) on October 17, 2025, with an average one-year price target of $5.79 per share, suggesting a 21.69% upside from its current price. This outlook comes despite projected annual revenue decreasing by 11.08% to $2,735 million and a non-GAAP EPS of $0.41. While the number of funds reporting positions in Schroders increased by 3.59% quarter-over-quarter, total shares owned by institutions decreased by 6.59% in the last three months, with several major institutional holders, including Oakmark and Vanguard funds, significantly reducing their stakes.

Analysis

UBS reiterated a "Buy" recommendation for Schroders (SHNWF) on October 17, 2025, with an average one-year price target of $5.79 per share, implying a significant 21.69% upside from its latest closing price of $4.76. This positive analyst outlook, however, contrasts with the company's projected financial performance, which includes an anticipated 11.08% decrease in annual revenue to $2,735 million and a non-GAAP EPS of $0.41.

Institutional ownership data presents a mixed signal, indicating a potential divergence in investor sentiment. While the number of funds reporting positions in SHNWF increased by 3.59% quarter-over-quarter, suggesting broader interest, the total shares owned by institutions collectively decreased by 6.59% over the last three months to 140,296K shares. This implies a net reduction in overall institutional exposure despite a wider distribution of holdings.

Further reinforcing this cautious institutional stance, several major holders, including Oakmark International Fund and Vanguard Total International Stock Index Fund, significantly reduced their stakes. These divestments ranged from 9.43% to 14.69% in share count, underscoring a notable reduction in conviction among some large-scale investors, which could temper the positive analyst sentiment.

Key Decisions for Investors

• Investors should carefully weigh UBS's reiterated "Buy" rating and 21.69% price target upside against the projected 11.08% decline in annual revenue and significant institutional share reductions.
• Monitor future earnings reports for any deviation from the projected $0.41 non-GAAP EPS and revenue trends, as these fundamental metrics appear to be a point of divergence from the analyst's bullish stance.
• Consider the implications of major institutional divestment, as this could signal underlying concerns not fully captured by the analyst's price target, suggesting a need for deeper due diligence into the reasons for these outflows.